Oncology Division
Alphabetical list (active faculty):   
Jesse W. Keller

Jesse W. Keller, MD

Assistant Professor

Department of Medicine

Oncology Division

Medical Oncology

Clinical Interests

  • Malignant melanoma


  • 314-747-8360 (office)
  • Division of Oncology
    Campus Box 8056
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid-Campus Center (office)

Original Articles

  • Advancing Age and the Risk of Bleomycin Pulmonary Toxicity in a Largely Older Cohort of Patients With Newly Diagnosed Hodgkin Lymphoma
    Thomas TS, Luo S, Reagan PM, Keller JW, Sanfilippo KM, Carson KR
    J Geriatr Oncol 2020 Jan;11(1):69-74
  • Predicting Venous Thromboembolism in Multiple Myeloma: Development and Validation of the IMPEDE VTE Score
    Sanfilippo KM, Luo S, Wang TF, Fiala MA, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller JW, Thomas TS, Carson KR, Gage BF
    Am J Hematol 2019 Nov;94(11):1176-1184
  • Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience
    Trikalinos NA, Zhou A, Doyle MBM, Fowler KJ, Morton A, Vachharajani N, Amin M, Keller JW, Chapman WC, Brunt EM, Tan BR
    J Natl Compr Canc Netw 2018 Oct;16(10):1193-1199
  • Stereotactic Radiosurgery and Immunotherapy in Melanoma Brain Metastases: Patterns of Care and Treatment Outcomes
    Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD
    Radiother Oncol 2018 Aug;128(2):266-273
  • Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA
    Carlson AL, Pastula DM, Lambert AJ, Staples JE, Muehlenbachs A, Turabelidze G, Eby CS, Keller J, Hess B, Buller RS, Storch GA, Byrnes K, Dehner L, Kirmani N, Kuhlmann FM
    Emerg Infect Dis 2018 May;24(5):893-897
  • Distant Intracranial Failure in Melanoma Brain Metastases Treated With Stereotactic Radiosurgery in the Era of Immunotherapy and Targeted Agents
    Acharya S, Mahmood M, Mullen D, Yang D, Tsien CI, Huang J, Perkins SM, Rich K, Chicoine M, Leuthardt E, Dowling J, Dunn G, Keller J, Robinson CG, Abraham C
    Adv Radiat Oncol 2017 Aug 12;2(4):572-580
  • Untreated Donor Specific Antibodies Against HLA Are Associated With Poor Outcomes in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation
    Zou J, Romee R, Slade M, Phelan D, Keller J, Mohanakumar T, Grossman BJ
    Bone Marrow Transplant 2017 Jun;52(6):898-901
  • Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy
    Krishnan A, Vij R, Keller J, Dhakal B, Hari P
    Am Soc Clin Oncol Educ Book 2016;35:210-21
  • Statins Are Associated With Reduced Mortality in Multiple Myeloma
    Sanfilippo KM, Keller J, Gage BF, Luo S, Wang TF, Moskowitz G, Gumbel J, Blue B, O'Brian K, Carson KR
    J Clin Oncol 2016 Nov 20;34(33):4008-4014
  • Severe Cytokine-Release Syndrome After T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated With Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated
    Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2016 Oct;22(10):1851-60
  • A Phase I Study of Thymoglobulin for Relapsed or Refractory Multiple Myeloma
    Keller J, Fiala MA, DiPersio J, Stockerl-Goldstein K, Vij R, Heldermon CD
    Leuk Lymphoma 2016 Feb;57(2):453-5
  • Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma
    Zhou A, Amin M, Fowler KJ, Brunt EM, Keller J, Tan B
    J Natl Compr Canc Netw 2015 Dec;13(12):1468-73
  • Risk-Adapted Strategies for the Treatment of Hodgkin Lymphoma
    Keller J, Carson KR
    Expert Opin Drug Saf 2015 Oct;14(10):1519-30
  • Targeted Treatments for Multiple Myeloma: Specific Role of Carfilzomib
    Sugumar D, Keller J, Vij R
    Pharmgenomics Pers Med 2015 Jan 20;8:23-33
  • Haploidentical Transplantation Using G-CSF-Mobilized T-Cell Replete PBSCs and Post-Transplantation CY After Non-Myeloablative Conditioning Is Safe and Is Associated With Favorable Outcomes
    Bhamidipati PK, DiPersio JF, Stokerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    Bone Marrow Transplant 2014 Aug;49(8):1124-6
  • Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
    Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL
    J Geriatr Oncol 2014 Jul;5(3):238-44
  • Integrin Alpha2 Mediates Selective Metastasis to the Liver
    Yoshimura K, Meckel KF, Laird LS, Chia CY, Park JJ, Olino KL, Tsunedomi R, Harada T, Iizuka N, Hazama S, Kato Y, Keller JW, Thompson JM, Chang F, Romer LH, Jain A, Iacobuzio-Donahue C, Oka M, Pardoll DM, Schulick RD
    Cancer Res 2009 Sep 15;69(18):7320-8
  • DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
    Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D
    J Clin Oncol 2009 Apr 10;27(11):1806-13

Book Chapters

  • Plasma Cell Dyscrasias
    Keller J, Vij R
    In: The Washington Manual of Oncology. 4th Edition. (Govindan R, ed)
  • Principles of Hematopoietic Cell Transplantation
    Keller J, Romee R
    In: The Washington Manual of Oncology. 4th Edition. (Govindan R, ed)